Literature DB >> 2453862

Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate.

C L Robinette1.   

Abstract

The subacute administration of estradiol-17 beta was shown to be a potent inducer of an inflammatory response specific to the lateral prostate of the castrated Wistar rat. The subsequent administration of dihydrotestosterone restored the wet weight of the gland while maintaining the inflammation established with estrogen treatment. These changes are histologically similar to a spontaneously arising nonbacterial prostatitis previously reported by others in the aging rat lateral prostate. When the same hormones were administered on a chronic basis, the intensity of the inflammation increased with time and was accompanied by a fibromuscular proliferation that consisted of fibroblasts, smooth muscle cells, and collagen. These chronic changes correlated well with studies by other investigators on human benign prostatic hyperplasia (BPH) where certain forms of BPH were associated with a significant degree of inflammation and fibromuscular growth. The present studies therefore establish a model system for the hormonal induction of an inflammatory reaction in the rat lateral prostate that precedes and could be causally related to proliferative responses in the fibromuscular stroma. The potentially important similarities that exist between these experimental findings and the human problems of nonbacterial prostatitis and benign prostatic hyperplasia warrant additional study.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453862     DOI: 10.1002/pros.2990120310

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  31 in total

1.  The picture of the prostatic lymphokine network is becoming increasingly complex.

Authors:  Georg E Steiner; Bob Djavan; Gero Kramer; Alessandra Handisurya; Martin Newman; Chung Lee; Michael Marberger
Journal:  Rev Urol       Date:  2002

Review 2.  Benign prostatic hyperplasia: a new metabolic disease?

Authors:  L Vignozzi; G Rastrelli; G Corona; M Gacci; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2014-01-24       Impact factor: 4.256

3.  Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Siobhan Sutcliffe; Robert L Grubb Iii; Elizabeth A Platz; Lawrence R Ragard; Thomas L Riley; Sally S Kazin; Richard B Hayes; Ann W Hsing; Gerald L Andriole
Journal:  BJU Int       Date:  2012-03-19       Impact factor: 5.588

Review 4.  Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

5.  Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer.

Authors:  Douglas G McNeel; Heath A Smith; Jens C Eickhoff; Joshua M Lang; Mary Jane Staab; George Wilding; Glenn Liu
Journal:  Cancer Immunol Immunother       Date:  2011-12-31       Impact factor: 6.968

6.  Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatments.

Authors:  Laura E Johnson; Jordan T Becker; Jason A Dubovsky; Brian M Olson; Douglas G McNeel
Journal:  Chin Clin Oncol       Date:  2013-03-01

7.  The effect of oestradiol-17 beta on connective tissue protein in rat prostate.

Authors:  T Nakada; Y Kubota; I Sasagawa; H Suzuki; M Watanabe; Y Suzuki
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

8.  Bladder function in 17β-estradiol-induced nonbacterial prostatitis model in Wistar rat.

Authors:  Seiji Matsumoto; Yuko Kawai; Michiko Oka; Tatsuya Oyama; Kazumi Hashizume; Naoki Wada; Jun-ichi Hori; Gaku Tamaki; Masafumi Kita; Tatsuya Iwata; Hidehiro Kakizaki
Journal:  Int Urol Nephrol       Date:  2013-04-25       Impact factor: 2.370

9.  Preventive effects of oligomerized polyphenol on estradiol-induced prostatitis in rats.

Authors:  Dong Suk Kim; Eun Jin Lee; Kang Su Cho; So Jung Yoon; Young Hoon Lee; Sung Joon Hong
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

10.  Etiopathogenesis of benign prostatic hypeprlasia.

Authors:  Jie Tang; Jingchun Yang
Journal:  Indian J Urol       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.